Expertise in
10
conditions

Antonio Micari

Messina, IT 
Expertise in
10
conditions
Messina, IT 

Overview

Antonio Micari practices practicing medicine in Messina, Italy.

Mr. Micari is highly rated in 10 conditions, according to our data. His clinical expertise encompasses Peripheral Artery Disease, Atherosclerosis, Heart Attack, Angioplasty, and Thrombectomy.

He is actively involved in clinical research, co-authoring 170 peer reviewed articles and participating in 5 clinical trials.

Gender

Male

Locations

Messina, Italy
Other Locations
Palermo, Italy
Humanitas Gavazzeni
Bergamo, Italy
Cotignola, Italy
Ravenna, Italy

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

5 Clinical Trials

Randomized Study of IN.PACT 014 Paclitaxel-Coated Percutaneous Transluminal Angioplasty Balloon Catheter vs. Optimal Percutaneous Transluminal Angioplasty for the Treatment of Chronic Total Occlusions in the Infrapopliteal Arteries
Randomized Study of IN.PACT 014 Paclitaxel-Coated Percutaneous Transluminal Angioplasty Balloon Catheter vs. Optimal Percutaneous Transluminal Angioplasty for the Treatment of Chronic Total Occlusions in the Infrapopliteal Arteries
Enrollment Status: Completed
Publish Date: July 08, 2025
Intervention Type: Device
Study Phase: Not Applicable
Randomized & Controlled Noninferiority Trial to Evaluate Safety & Clinical Efficacy of SurVeil™ Drug-Coated Balloon (DCB) iN Treatment of Subjects With Stenotic Lesions of Femoropopliteal Artery Compared to Medtronic IN.PACT® Admiral® DCB
Randomized & Controlled Noninferiority Trial to Evaluate Safety & Clinical Efficacy of SurVeil™ Drug-Coated Balloon (DCB) iN Treatment of Subjects With Stenotic Lesions of Femoropopliteal Artery Compared to Medtronic IN.PACT® Admiral® DCB
Enrollment Status: Completed
Publish Date: March 25, 2025
Intervention Type: Device
Study Phase: Not Applicable
Prospective, Single-Arm, Global Multi-Center Study to Evaluate Treatment of Obstructive Superficial Femoral Artery (SFA) and/or Popliteal Lesions With a Novel Paclitaxel-Coated Percutaneous Angioplasty (PTA) Balloon and in In-Stent Restenosis
Prospective, Single-Arm, Global Multi-Center Study to Evaluate Treatment of Obstructive Superficial Femoral Artery (SFA) and/or Popliteal Lesions With a Novel Paclitaxel-Coated Percutaneous Angioplasty (PTA) Balloon and in In-Stent Restenosis
Enrollment Status: Completed
Publish Date: March 24, 2023
Intervention Type: Device
Study Phase: Not Applicable
A Prospective, Multicenter, Single Blind, Randomized, Controlled Trial Comparing the Lutonix Drug Coated Balloon Versus Standard Balloon Angioplasty for Treatment of Below-the-Knee (BTK) Arteries(Lutonix BTK Trial)
A Prospective, Multicenter, Single Blind, Randomized, Controlled Trial Comparing the Lutonix Drug Coated Balloon Versus Standard Balloon Angioplasty for Treatment of Below-the-Knee (BTK) Arteries(Lutonix BTK Trial)
Enrollment Status: Completed
Publish Date: February 09, 2022
Intervention Type: Device
Study Phase: Not Applicable
Relationship Between Coronary Plaque Morphology of Left Anterior Descending Artery and Long Term Clinical Outcome: the CLIMA Study
Relationship Between Coronary Plaque Morphology of Left Anterior Descending Artery and Long Term Clinical Outcome: the CLIMA Study
Enrollment Status: Unknown
Publish Date: December 21, 2017
Intervention Type: Procedure
View 4 Less Clinical Trials

170 Total Publications

How short is short enough? Reframing dual antiplatelet therapy duration in the contemporary percutaneous coronary intervention era.
How short is short enough? Reframing dual antiplatelet therapy duration in the contemporary percutaneous coronary intervention era.
Journal: Heart (British Cardiac Society)
Published: August 24, 2026

Frequently Asked Questions about Antonio Micari

Is Antonio Micari a top-rated expert for Angioplasty?

MediFind is an objective health platform that identifies experts based on real-world data. Antonio Micari is classified as an Distinguished expert for Angioplasty, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Antonio Micari participate in research or clinical trials?

Yes. Antonio Micari has published 170 articles and abstracts on conditions like Angioplasty. You can view a list of Antonio Micari's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Micari's expertise for a condition
ConditionClose
    View All 7 Advanced Conditions
    View All 40 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile